(Q72655178)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260240%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Circadian rhythm-modulated chemotherapy with high-dose 5-fluorouracil: a pilot study in patients with pancreatic adenocarcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260240%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

pancreatic adenocarcinoma

1 reference

1 reference

1 reference

F Bertheault-Cvitkovic

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260240%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

F Lévi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260240%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

S Soussan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260240%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

S Brienza

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260240%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

R Adam

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260240%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

M Itzhaki

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260240%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

J L Misset

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260240%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

H Bismuth

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260240%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260240%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

28 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260240%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

29A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260240%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260240%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

1851-1854

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260240%20AND%20SRC:MED&resulttype=core&format=json

10.1016/0959-8049(93)90536-O

28 October 2019

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8260240%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference